-+ 0.00%
-+ 0.00%
-+ 0.00%

NurExone signs binding MOU with Made Scientific for exclusive US GMP exosome manufacturing partnership

PUBT·08/12/2026 21:03:08
Listen to the news
NurExone signs binding MOU with Made Scientific for exclusive US GMP exosome manufacturing partnership
  • NurExone Biologic signed a binding MOU with Made Scientific for an exclusive U.S. GMP manufacturing partnership for bone marrow-derived exosomes.
  • Made Scientific to handle U.S. manufacturing, aseptic fill-finish, commercial exosome supply to support clinical development.
  • Technology transfer to start immediately; first GMP exosome batches targeted for H1 2027.
  • MOU contemplates a 5-year term with 5-year renewal options; exclusivity ends if no definitive deal within six months.
  • Company dropped its earlier non-binding LOI with BioXtek as it consolidates U.S. GMP manufacturing under Made Scientific.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NurExone Biologic Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608121702PRIMZONEFULLFEED9809058) on August 12, 2026, and is solely responsible for the information contained therein.